What is the address of ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY?

The registered office of ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY is located at Gaversstraat(SGW) 79, 9170 Sint-Gillis-Waas.

Is ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY still active?

Yes. According to the CBE (31 October 2026) ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY is active, legal situation “Normale toestand”, started on 5 November 1996.

Is ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY registered on Peppol?

Yes, ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY is registered on the Peppol network with ID 0208:0459170383.

What is the enterprise number of ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY?

The enterprise number of ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY is BE0459170383.

Who are the directors of ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY?

According to the 2026 annual accounts, the directors of ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY are: Willy Dullaert.

Is ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 November 1996; 5 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account.

How much profit did ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY make in 2026?

ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY recorded a loss after taxes of € 14,176 in financial year 2026.

What is the revenue of ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY?

As a small company, ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € -1,358.

ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY (Private Limited)

Q: What does ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY do?

ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 5 November 1996, 1 establishment.

Q: When was ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY founded?

ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY was founded on 5 November 1996.

Dossier ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY, printed on 1 November 2026 from databakkes.be/en/0459170383/engineering-consultancy-medical-technology. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2025 and 2026.

Financials

Financial year 2026

ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY from Sint-Gillis-Waas, company number BE0459170383, closed financial year 2026 with a result of € -14,176 after tax. For that financial year ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY recorded a gross margin of € -1,358 and equity of € 497,164. Compared with financial year 2025, the result moved from € -5,024 to € -14,176. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 12, 2026.

What it is worth Healthy

€ 497,164

▼ 7% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -14,176

▼ 182 % more loss than in 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 193,916

▼ 25% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 478,572.

People and assets in 2026

Vehicles and equipment

€ 835

▼ 37% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 68,526

▼ 11% vs 2025

€ 8,346 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 303

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 119

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 2,488 Gross margin 2023: € 2,488 First fiscal year in the series	€ -3,653 Gross margin 2024: € -3,653 ▼ € 6,141 vs 2023 (€ 2,488) Unfavourable step	€ -478 Gross margin 2025: € -478 ▲ € 3,175 vs 2024 (€ -3,653) Favourable step	€ -1,358 Gross margin 2026: € -1,358 ▼ € 880 vs 2025 (€ -478) Unfavourable step	▼ € 880
Profit after taxes	€ -16,647 Profit after taxes 2023: € -16,647 First fiscal year in the series	€ -1,883 Profit after taxes 2024: € -1,883 ▲ € 14,764 vs 2023 (€ -16,647) Favourable step	€ -5,024 Profit after taxes 2025: € -5,024 ▼ € 3,141 vs 2024 (€ -1,883) Unfavourable step	€ -14,176 Profit after taxes 2026: € -14,176 ▼ € 9,152 vs 2025 (€ -5,024) Unfavourable step	▼ € 9,152
Equity	€ 621,247 Equity 2023: € 621,247 First fiscal year in the series	€ 541,364 Equity 2024: € 541,364 ▼ 13% vs 2023 (€ 621,247) Unfavourable step	€ 536,340 Equity 2025: € 536,340 ▼ 1% vs 2024 (€ 541,364) Unfavourable step	€ 497,164 Equity 2026: € 497,164 ▼ 7% vs 2025 (€ 536,340) Unfavourable step	▼ 7%
Total debts	€ 109,084 Total debts 2023: € 109,084 First fiscal year in the series	€ 180,898 Total debts 2024: € 180,898 ▲ 66% vs 2023 (€ 109,084) Unfavourable step	€ 163,347 Total debts 2025: € 163,347 ▼ 10% vs 2024 (€ 180,898) Favourable step	€ 176,970 Total debts 2026: € 176,970 ▲ 8% vs 2025 (€ 163,347) Unfavourable step	▲ 8%
Cash	€ 412,926 Cash 2023: € 412,926 First fiscal year in the series	€ 276,801 Cash 2024: € 276,801 ▼ 33% vs 2023 (€ 412,926) Unfavourable step	€ 256,908 Cash 2025: € 256,908 ▼ 7% vs 2024 (€ 276,801) Unfavourable step	€ 193,916 Cash 2026: € 193,916 ▼ 25% vs 2025 (€ 256,908) Unfavourable step	▼ 25%
Land & buildings	€ 224,350 Land & buildings 2023: € 224,350 First fiscal year in the series	€ 219,857 Land & buildings 2024: € 219,857 ▼ 2% vs 2023 (€ 224,350) Unchanged	€ 213,194 Land & buildings 2025: € 213,194 ▼ 3% vs 2024 (€ 219,857) Unchanged	€ 207,901 Land & buildings 2026: € 207,901 ▼ 2% vs 2025 (€ 213,194) Unchanged	▼ 2%
Retained profit	€ 602,655 Retained profit 2023: € 602,655 First fiscal year in the series	€ 522,772 Retained profit 2024: € 522,772 ▼ 13% vs 2023 (€ 602,655) Unfavourable step	€ 517,748 Retained profit 2025: € 517,748 ▼ 1% vs 2024 (€ 522,772) Unfavourable step	€ 478,572 Retained profit 2026: € 478,572 ▼ 8% vs 2025 (€ 517,748) Unfavourable step	▼ 8%
Dividend	€ 0 Dividend 2023: € 0 First fiscal year in the series	€ 78,000 Dividend 2024: € 78,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 78,000) Unchanged	€ 25,000 Dividend 2026: € 25,000 Unchanged (€ 0) Unchanged
Bank debt	€ 92,736 Bank debt 2023: € 92,736 First fiscal year in the series	€ 84,802 Bank debt 2024: € 84,802 ▼ 9% vs 2023 (€ 92,736) Favourable step	€ 76,733 Bank debt 2025: € 76,733 ▼ 10% vs 2024 (€ 84,802) Favourable step	€ 68,526 Bank debt 2026: € 68,526 ▼ 11% vs 2025 (€ 76,733) Favourable step	▼ 11%
Balance sheet total	€ 730,331 Balance sheet total 2023: € 730,331 First fiscal year in the series	€ 722,262 Balance sheet total 2024: € 722,262 ▼ 1% vs 2023 (€ 730,331) Unchanged	€ 699,686 Balance sheet total 2025: € 699,686 ▼ 3% vs 2024 (€ 722,262) Unchanged	€ 674,134 Balance sheet total 2026: € 674,134 ▼ 4% vs 2025 (€ 699,686) Unchanged	▼ 4%

Key figures of ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY?

What happened at ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 12, 2026 New annual accounts for financial year 2026: loss of € 14,176. Source: NBB ↗
Nov 21, 1996 New establishment in Sint-Gillis-Waas. KBO
Nov 5, 1996 Start of the company according to the CBE. KBO
1996 Willy Dullaert became a director. NBB

In short

From € 16,648 loss in 2023 to € 14,176 loss in 2026.

Paid € 2,014 in corporate taxes since 2023.

Paid out € 103,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Willy Dullaert

ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY

Behind ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY is Willy Dullaert.

Directors

According to the 2026 annual accounts

Willy Dullaert

Director

since 1996

Establishments

Establishment units

Physical locations of this company

Registered office

Gaversstraat(SGW) 79

9170 Sint-Gillis-Waas

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0459.170.383

VAT number

BE 0459.170.383

Registered office

Gaversstraat(SGW) 79, 9170 Sint-Gillis-Waas

Names & denominations

ENGINEERING CONSULTANCY MEDICAL TECHNOLOGY · ECMT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

5 November 1996

Peppol

Active · Active since 5 Oct 2025

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Reparatie en onderhoud van computers en communicatieapparatuur

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

Organisatie van congressen en beurzen

Detailhandel in ICT-apparatuur

Reparatie van computers en randapparatuur

View on CBE Public ↗ Annual accounts (NBB) ↗